bioAffinity Technologies, Inc. (BIAF) Total liabilities 2022–2025
bioAffinity Technologies, Inc. (BIAF) total liabilities at each fiscal year-end, per SEC filings.
$3.7MFY2025 · since FY2022: $1.1M → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7M | -5.8% |
| FY2024 | $3.9M | +16.2% |
| FY2023 | $3.4M | +195.6% |
| FY2022 | $1.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAF financial trends
BIAF RevenueBIAF Net incomeBIAF Net marginBIAF Gross profitBIAF Gross marginBIAF Operating incomeBIAF Operating marginBIAF Operating cash flowBIAF Free cash flowBIAF Capital expendituresBIAF Return on equityBIAF Stock buybacksBIAF Dividends paidBIAF Total assetsBIAF Shareholders’ equityBIAF overview →